Literature DB >> 15184623

Patterns of cannabis use among patients with multiple sclerosis.

A J Clark1, M A Ware, E Yazer, T J Murray, M E Lynch.   

Abstract

To estimate the patterns and prevalence of cannabis use among patients with multiple sclerosis (MS), 220 patients were surveyed in Halifax, Nova Scotia. Seventy-two subjects (36%) reported ever having used cannabis for any purpose; 29 respondents (14%) reported continuing use of cannabis for symptom treatment. Medical cannabis use was associated with male gender, tobacco use, and recreational cannabis use. The symptoms reported by medical cannabis users to be most effectively relieved were stress, sleep, mood, stiffness/spasm, and pain.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15184623     DOI： 10.1212/01.wnl.0000127707.07621.72

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  35 in total

Review 1.  Complementary and alternative medicine: is there a role in multiple sclerosis?

Authors:  Vijayshree Yadav; Dennis Bourdette
Journal:  Curr Neurol Neurosci Rep       Date:  2006-05       Impact factor: 5.081

Review 2.  In the weeds: a baseline view of cannabis use among legalizing states and their neighbours.

Authors:  Rosalie Liccardo Pacula; Mireille Jacobson; Ervant J Maksabedian
Journal:  Addiction       Date:  2016-01-26       Impact factor: 6.526

Review 3.  The pharmacotherapy of chronic pain: a review.

Authors:  Mary E Lynch; C Peter N Watson
Journal:  Pain Res Manag       Date:  2006       Impact factor: 3.037

4.  Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?

Authors:  Dayong Lee; Erin L Karschner; Garry Milman; Allan J Barnes; Robert S Goodwin; Marilyn A Huestis
Journal:  Drug Alcohol Depend       Date:  2012-11-10       Impact factor: 4.492

5.  Effects of cannabis on cognitive function in patients with multiple sclerosis.

Authors:  Kimia Honarmand; Mary C Tierney; Paul O'Connor; Anthony Feinstein
Journal:  Neurology       Date:  2011-03-29       Impact factor: 9.910

6.  Urinary concentrations of PAH and VOC metabolites in marijuana users.

Authors:  Binnian Wei; K Udeni Alwis; Zheng Li; Lanqing Wang; Liza Valentin-Blasini; Connie S Sosnoff; Yang Xia; Kevin P Conway; Benjamin C Blount
Journal:  Environ Int       Date:  2015-12-12       Impact factor: 9.621

7.  Prevalence and determinants of cannabinoid prescription for the management of chronic noncancer pain: a postal survey of physicians in the Abitibi-Témiscamingue region of Quebec.

Authors:  Huguette St-Amant; Mark A Ware; Nancy Julien; Anaïs Lacasse
Journal:  CMAJ Open       Date:  2015-04-02

Review 8.  Cannabinoids and multiple sclerosis.

Authors:  Roger G Pertwee
Journal:  Mol Neurobiol       Date:  2007-06-26       Impact factor: 5.590

9.  Relief-oriented use of marijuana by teens.

Authors:  Joan L Bottorff; Joy L Johnson; Barbara M Moffat; Tamsin Mulvogue
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-04-23

Review 10.  Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review.

Authors:  Shaheen E Lakhan; Marie Rowland
Journal:  BMC Neurol       Date:  2009-12-04       Impact factor: 2.474
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.